# Tudriqev

NDC: 83616-107
Generic name: vusolimogene oderparepvec-wtpg
Labeler / Manufacturer: Replimune, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: INTRATUMOR
Marketing started: 20260904

FDA application: BLA125827

## Active ingredients

- VUSOLIMOGENE ODERPAREPVEC: 10000000 [PFU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83616-107"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83616-107